Stocks & Options
Trading Strategies
Institutional Holdings Directory
SEC Filings TLDR
Analysis Reports
AI Tools
EN
Sign in
NURIX THERAPEUTICS, INC. Reports Q2 2026 Financial Results
2026-07-09
SEC Filing 10-Q
(0001549595-26-000040)
Please check the link below for details.
Ticker mentioned:
NRIX
Source:
Original SEC Document β